Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest Leishmania Stories

2014-02-20 23:23:09

Unhealing Ulcers Afflict Millions, Including U.S. Troops; UVA IDs Promising Treatment Charlottesville, VA (PRWEB) February 20, 2014 A protozoan parasite that causes unhealing, potentially disfiguring skin sores appears to have a weakness for gold. Researchers have discovered that an existing gold-based drug is toxic to the microscopic parasite that causes the disease known as cutaneous leishmaniasis, a condition that affects millions, including U.S. troops. The discovery is notable...

2014-01-17 11:34:13

Research involving scientists at the University of York has provided important new information about transmission of human leishmaniasis, a group of infectious diseases which kills more than 100,000 people a year. Professor Deborah Smith of the Centre for Immunology and Infection at York, working with colleagues at the Wellcome Trust Sanger Institute and Charles University in Prague, has shown that Leishmania parasites reproduce sexually in the wild. The research, published in PLOS...

2014-01-10 11:36:39

A new way to test for the parasite which causes the fatal disease leishmaniasis could help control its spread to humans and stop dogs being needlessly killed in parts of South America A new way to test for the parasite which causes the fatal disease leishmaniasis could help control its spread to humans and stop dogs being needlessly killed in parts of South America. Zoonotic visceral leishmaniasis is a vector-transmitted parasitic infection which can be fatal if left untreated. It...

2014-01-03 15:54:30

Caught in the act! Researchers from the University of Bristol have observed mating for the first time in the microbes responsible for African sleeping sickness. This tropical disease is caused by trypanosomes, single-celled parasites that are found in the blood of those afflicted. The Bristol team were able to see what the trypanosomes were getting up to inside the tsetse flies that carry the disease by using fluorescent markers [see image – link below]. The microscopic beasts were seen...

2013-11-05 10:26:49

An 83 percent improvement in efficacy in the drug most commonly used to treat leishmaniasis The Amphotericin B (AmB) is the main active ingredient in the most effective drug used to treat leishmaniasis, a disease which in the Western world mainly affects dogs, but in developing countries affects over 12 million people, with more than 70,000 deaths per year. The cost of treating humans with AmB surpasses $5,000 per patient, the treatment is extensive (2-hour sessions every day during 21...

2013-10-18 11:24:28

Leishmaniasis is a vector borne disease caused by different Leishmania species with different clinical manifestations. Cutaneous leishmaniasis (CL) is endemic and widespread especially among young individuals in Iran. Currently prophylactic or therapeutic vaccines are not available, and in spite of vector control wherever possible, the disease has not been controlled. Although the majority of zoonotic CL cases heal within 6-9 months, anthroponotic cases persist much longer. Both types leave...

2013-10-08 13:58:05

Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio®, the online open-access journal of the American Society for Microbiology. Visceral leishmaniasis, also called kala-azar, is a parasitic disease that strikes 400,000 people every year and kills around 1 in 10 of its victims. The disease has proven difficult to treat, in part because a large...

2012-12-19 15:19:36

Leishmaniasis is the second most mortal tropical parasitic disease A research coordinated by the UAB has succeeded in testing a vaccine against leishmaniasis. The vaccine was tested with the best animal model existing, the golden hamster, and can be produced at low costs by using insect larvae. The research, published in the latest edition of PLoS ONE, is an important step towards the fight against a disease which causes the death of 70,000 people each year in developing countries and of...

2012-07-20 00:15:00

Genome research for the health of the poorest of the poor Belgian scientists of the Institute of Tropical Medicine (ITM) in Antwerp, Belgium made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. After sequencing the complete genome of Leishmania donovani (a parasite causing one of the most important tropical diseases after malaria) in hundreds of clinical isolates, they identified a series of mutations specific...

2012-05-21 23:54:22

DNDi welcomes World Health Organization expert recommendations to begin negotiations for an R&D convention at the World Health Assembly After a decade-long process of analysis and deliberations on ways to better address the health needs of developing countries, a recently released report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) will be discussed this week at the 65th World Health Assembly (agenda item 13.14). The Drugs for...


Latest Leishmania Reference Libraries

42_edd0051356ea81ea05e25b425c16e817
2007-01-19 19:37:55

Egyptian Mongoose (Herpestes ichneumon) is found in Africa and Spain, quite commonly in Sudan. It has recently been discovered as being a reservoir host for Visceral Leishmaniasis in Sudan.

More Articles (1 articles) »